Valens GroWorks Corp (CSE:VGW,OTC:VGWCF) has released an in-depth article on the chemistry of the cannabis plant and its compounds and highlighted the need for extraction. According to Valens, extraction is necessary to purify and concentrate select compounds from the cannabis plant. When done correctly, extraction can provide pure and isolated compounds free of impurities that can negatively affect a user’s experience.

There are multiple extraction methods. Most methods utilize temperature, pressure, solvents and time to access the cannabinoids, flavonoids and terpenes present in cannabis. Regardless of the extraction method, extraction results in a more concentrated product, which can be dangerous if the plant contains toxins or heavy metals before being processed.

As one of the largest third-party cannabis extraction companies in Canada, Valens tests, analyzes and produces cannabis extracts for medical and recreational cannabis distributors. The company offers large capacity, in-house quality testing and various extraction services to other licensed producers such as Canopy Growth (TSX:WEED), Harvest One (TSXV:HVT) and Tilray (NASDAQ:TLRY), among others. Valens is currently able to process 240,000 kilograms of cannabis and meticulously tests its products for purity and safety throughout the process.

Overall, Valens believes that the future of the cannabis industry is moving towards extraction due to its versatility. Cannabis extracts can be packaged into oil capsules, vape cartridges and edibles, among other products. By offering several different extraction methods, Valens can ethically and sustainably produce various products for its clients with a wide array of cannabinoid and terpene profiles.

“The future of cannabis in Canada is coming and we are going to be at the forefront,”  said Valens CEO Tyler Robson.

To view the full article, click here.

Click here to connect with Valens GroWorks Corp (CSE:VGW,OTC:VGWCF)  for an Investor Presentation. 

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less